Short answer · Medically reviewed summary · Last updated: 2026-05-08
Currently, there is no universal cure for Adrenal Cortical Carcinoma (ACC), particularly when the disease is advanced or metastatic at the time of diagnosis. However, aggressive treatment strategies, including surgical resection and systemic therapies, can achieve long-term remission in some patients and effectively manage symptoms to improve quality of life. Can Adrenal Cortical Carcinoma (ACC) be cured? Complete surgical removal (R0 resection) remains the only potentially curative treatment for Adrenal Cortical Carcinoma (ACC) when the tumor is localized.
2 people with Adrenal Cortical Carcinoma (ACC) have shared their first-person experience on this question at DiseaseMaps.
Does Adrenal Cortical Carcinoma (ACC) have a cure?
Is there a cure for Adrenal Cortical Carcinoma (ACC)? Current treatment landscape and research progress, medically reviewed, plus patient experiences.
Currently, there is no universal cure for Adrenal Cortical Carcinoma (ACC), particularly when the disease is advanced or metastatic at the time of diagnosis. However, aggressive treatment strategies, including surgical resection and systemic therapies, can achieve long-term remission in some patients and effectively manage symptoms to improve quality of life.
Can Adrenal Cortical Carcinoma (ACC) be cured?
Complete surgical removal (R0 resection) remains the only potentially curative treatment for Adrenal Cortical Carcinoma (ACC) when the tumor is localized. For patients where the disease has spread, the focus shifts to disease modification and life extension. At DiseaseMaps.org, 265 community members share diverse experiences with treatment paths, reflecting the complexity of managing this rare malignancy.
What are the current treatment standards for Adrenal Cortical Carcinoma (ACC)?
Because Adrenal Cortical Carcinoma (ACC) is highly aggressive, treatment often requires a multidisciplinary approach. Current standard-of-care options include:
- Surgical Resection: The primary intervention to remove the tumor and affected lymph nodes.
- Mitotane Therapy: An adrenolytic medication often used as an adjuvant therapy to prevent or delay recurrence.
- Systemic Chemotherapy: Combination regimens, such as EDP-M (etoposide, doxorubicin, cisplatin, and mitotane), used for advanced-stage disease.
- Radiation Therapy: Primarily used for palliation or to control local recurrence.
What research is shaping the future of Adrenal Cortical Carcinoma (ACC) care?
Research into Adrenal Cortical Carcinoma (ACC) is rapidly evolving through precision medicine. Scientists are investigating molecular profiling to identify specific genetic drivers, such as TP53 mutations or IGF2 overexpression. Emerging clinical trials are currently evaluating targeted therapies, including immunotherapy (checkpoint inhibitors) and tyrosine kinase inhibitors, which aim to stop tumor growth at the cellular level. While these breakthroughs are promising, they are currently in investigative phases, and timelines for widespread clinical availability remain tied to ongoing trial success.
Next steps
- Consult with an endocrinologist or oncologist specializing in adrenal malignancies.
- Visit ClinicalTrials.gov to search for active trials specifically for Adrenal Cortical Carcinoma (ACC).
- Connect with the 265 members at DiseaseMaps.org to share experiences and find support.
- Monitor updates from the American Association of Endocrine Surgeons for the latest clinical guidelines.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always consult with your healthcare provider regarding your specific condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Adrenal Cortical Carcinoma
- Orphanet: Adrenocortical carcinoma
- American Cancer Society: Treating Adrenal Cortical Carcinoma
- National Cancer Institute (NCI): Adrenal Gland Tumor Treatment (PDQ®)
Posted Jun 11, 2017 by Grace 500
Posted Mar 9, 2018 by Accmom 2500
